Recipharm appoints President Development Services to drive end to end offering

February 14, 2018

Contract development and manufacturing organisation (CDMO) Recipharm has appointed Bernard Pluta to lead its new global development organisation. The newly established position forms part of the ongoing transformation of Recipharm’s Development Services, in which a total of 400 employees across six countries are united to deliver a comprehensive development offering. The scientific, chemical and pharmaceutical expertise will cover […]

ADC Bio developing downstream bioconjugation process

February 12, 2018

12 February 2018, Wales:ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing. In contrast to the existing approaches – which undertake bioconjugation after both the mAb and cytotoxic have been manufactured – this new approach moves […]

B. Braun’s first PAS-X V3 project successfully implemented

January 23, 2018

B. Braun’s first PAS-X V3 project successfully implemented Upgrade to PAS-X 3.1.8 at plant A in Melsungen / Integration of ERP and DCS / Extension to full-scope MES and roll-out to other German sites planned Lüneburg, Germany, January 23, 2018 – B. Braun successfully updated their existing PAS-X system from PAS-X V2 to PAS-X V3 […]

Japanese pharma: No longer ‘lost in translation’

January 15, 2018

Amsterdam, 15th January 2018: A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead of what is likely to be the largest ever CPhI Japan (18-20 April, 2018) – has identified that demographic pressures […]